Measuring the activity or expression levels of signaling molecules (FAS, ATGL, LPL, PPARs, MMPs, α-SMA, and certain indicative proteins) and transcription factors can provide insights into their mechanisms of action in fibrosis, metabolic disorders, and chronic diseases. Here, FAS is linked to metabolic disease.